GPC3-CART

GPC3-targeted CAR-T cells · Shanghai GeneChem Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GPC3-CART, covering 2017-04-26 to 2017-04-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART) [Phase 1, Phase 2]